Henok Eyob

University of Utah — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

8h-index1.8kcitations13works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(4), Cancer, Lipids, and Metabolism(3), Macrophage Migration Inhibitory Factor(3), Cancer Mechanisms and Therapy(3), Metabolomics and Mass Spectrometry Studies(2)

Publications13 total

Inhibiting an RBM39/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferation
Cell Reports·2021· 25 citedOpen Access
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
Nature Medicine·2016· 164 cited
Abstract 2673: Inhibition of fatty-acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
Cancer Research·2016
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
Nature Medicine·2016· 523 citedOpen Access
Abstract PD3-05: Inhibition of fatty-acid oxidation as a therapy for triple-negative breast cancer
Cancer Research·2016
Abstract B34: PIM kinase as a novel therapeutic target for triple-negative breast cancer
Molecular Cancer Research·2016
Abstract A03: Integrative analyses reveal distinct metabolic dysregulation in MYC-driven, basal breast cancer
Molecular Cancer Research·2015
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Nature·2015· 907 citedOpen Access
RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
OncoImmunology·2013· 23 citedOpen Access
Inhibition of Ron Kinase Blocks Conversion of Micrometastases to Overt Metastases by Boosting Antitumor Immunity
Cancer Discovery·2013· 73 citedOpen Access
Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase
Genes & Cancer·2011· 43 cited
The Macrophage Stimulating Protein/Ron Pathway as a Potential Therapeutic Target to Impede Multiple Mechanisms Involved in Breast Cancer Progression
Current Drug Targets·2010· 55 cited
The Macrophage Stimulating Protein/Ron Pathway as a Potential Therapeutic Target to Impede Multiple Mechanisms Involved in Breast Cancer Progression
Current Drug Targets·2010· 5 cited

Frequent Co-authors

Sanjeev Balakrishnan(7), Andrei Goga(7), Alicia Y. Zhou(6), Roman Camarda(6), Brittany Anderton(6), Alana L. Welm(6), Devon A. Lawson(3), Kai Kessenbrock(3), Paul Yaswen(3), Zena Werb(3), Rebecca A. Kohnz(3), Céline I. Mahieu(3), Gregor Krings(3), Daniel K. Nomura(3), Saundra S. Buys(3), Shingo Kajimura(2), Aaron D. Tward(2), Dai Horiuchi(2), Christina Yau(2), Alexandra Corella(2)